DISCO Pharmaceuticals (“DISCO”) announced a strategic collaboration and option-to-license agreement with AbbVie to discover and develop novel A...
Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for p...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced a collaboration with Grupo Fleury, one of Brazil's ...
DPTX8743 is a potential first-in-class small molecule modulator of MYC condensates, targeting one of cancer’s most important and historically undrugg...
Santhera Pharmaceuticals (SIX: SANN) announces it has signed an exclusive agreement with SteinCares for the distribution of AGAMREE® (vamorolone) for t...
Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pela...
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), is pleased...
Cornerstone Robotics, an innovative surgical robotics company founded and headquartered in Hong Kong, today hosted the inaugural Surgical Futures Forum at ...
Partnership brings together decades of pancreatin experience at Nordmark and Essential Pharma Norzyme® (pancreas powder) 25,000 gastro-resistant capsu...
iDEL Therapeutics announced that it has entered into a research collaboration with Daiichi Sankyo (TSE: 4568) to utilize iDEL’s synthetic shuttl...
MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines Collaboration c...
Partnership provides opportunities to further expand Boehringer Ingelheim’s portfolio of antibody-drug conjugates (ADCs) and T-cell engagers (TcEs)...
Ambrose Healthcare’s acquisition of AM-Pharma, valued at up to €161 million plus royalties, strengthens its rare disease pipeline and establishe...
Blackstone Life Sciences (“BXLS”) announced a $455 million collaboration with Boston Scientific Corporation (NYSE: BSX) to co-fund the developm...
© 2026 Biopharma Boardroom. All Rights Reserved.